Journa

Journa is a precision health and biotechnology company focused on metabolic health and longevity. Originally founded as Journene, the company leverages biological insights and multi-omics data to develop both therapeutic interventions and personalized health platforms. Its therapeutic arm focuses on protein degradation pathways, specifically targeting F-box proteins like Fbxo7 for the treatment of age-related neurodegenerative conditions such as Parkinson's disease. Simultaneously, Journa provides a consumer-facing digital health platform that utilizes AI and biological testing to offer personalized nutrition and metabolic optimization strategies. By combining drug discovery with real-world biological monitoring, the company aims to extend human healthspan and prevent chronic disease.